Clinical Trial Update: Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating a CMV-specific monoclonal antibody for ocular complications in AIDS patients with Cytomegalovirus retinitis; results have been comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Retinitis
• HIV Infection

Drugs mentioned

• MACRT monoclonal antibody (CMV-specific monoclonal antibody)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: HIV Infections, Cytomegalovirus Retinitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-11-17